We propose a unifying model which can explain, the 1/f nature of electrophysiological spectra, 48 their dynamic interaction with oscillatory rhythms as well as the sensitivity of 1/f activity to 49 excitation-inhibition balance by considering electrophysiological spectra as being generated by a 50 collection of stochastically perturbed damped oscillators having a distribution of relaxation rates. 51 52 53
54
Numerous physical systems display scale-free (also termed fractal) temporal dynamics, 56 characterised by power-law (1/f ) spectral densities. Temporal signals displaying power-law 57 behaviour have been observed throughout the nervous system at various spatial scales, from 58 membrane potentials 1 , single channel currents 2 , and the spiking activity populations of neurons 59 3 through to the more global activities measured by electrocorticography, electroencephalography 60 and magnetoencephalography (ECoG/EEG/MEG) 4-6 and functional magnetic resonance imaging 61 7 . The potential functional importance of power law scaling in the brain is underscored by its 62 alteration in neuropsychiatric conditions [8] [9] [10] , ageing 11, 12 , and its dynamic modification in task 63 states 7, [12] [13] [14] [15] [16] . Despite this, the physiologic mechanisms by which power-law scalings are generated 64 is poorly understood and their significance remains controversial 17, 18 . In particular, it has been 65 argued that the existence of power laws in the brain might indicate that the brain is in a state of 66 self-organised criticality, where it is sensitively poised on a boundary between two qualitatively 67 different dynamical states, potentially an optimal state for information transmission 16, 19, 20 . 68
Alternatively, with respect to ECoG/EEG/MEG, it has been demonstrated that the 1/f properties 69 of underlying local field potentials can potentially be explained by low-pass filtering of ionic 70 current flow at dendritic processes, through the incorporation of their inherent geometric and 71 capacitive properties 21, 22 . Similarly, it has been shown that 1/f power spectra can be created by 72 ionic current flow in a convoluted extracellular space, if the media is considered as a complex 73 arrangement of resistors and capacitors 23, 24 . 74
For decades, the dominant approach to the analysis of ECoG/EEG/MEG has been to 75 consider either band-limited power changes, in the attempt to characterise brain rhythms, or 76 evoked responses, while the background activity is often regarded as "1/f noise". However, it has 77 been noted that the 1/f activity forms the bulk of the content of the ECoG/EEG/MEG 13, 25, 26 and 78 actually very little of the activity present in recordings with these modalities can mathematically 79 be classified as rhythmical 27 . Indeed, even when oscillations do occur, they frequently have a 80 non-sinusoidal morphology 28 . This is at odds with the view that the ECoG/EEG/MEG arises from 81 the collective behaviour of a large set of independent oscillators, and instead is consistent with the 82 idea of generators interacting in complex cross-frequency, often broadband patterns 25 . In our 83 previous pharmaco-EEG/MEG studies we have observed that drug-induced changes of cortical 84 power often show broadband spectral changes that cross the classically defined EEG frequency 85 ranges, suggesting that underlying 1/f activity may be pharmacologically sensitive [29] [30] [31] [32] . 86
Accurate estimation of the 1/f spectral component of the measurement of the 87 ECoG/EEG/MEG, and in particular the value of , is however, non-trivial in empirical data. Aftertransformation of the power spectrum to log-log coordinates can in theory simply be estimated 89 by standard least squares regression (P = 1/f , ≡ log(P) = -log(f)). However, as ECoG/EEG/MEG 90 recordings are a compound mixture of non-stationary oscillatory rhythms, potentially with 91 harmonic components, overlying the 1/f spectrum, these oscillations can substantially bias 92 estimation. Nevertheless, various investigators have provided estimates of with the values 93 obtained varying depending on the analysis technique used and the recording modality studied 4, 94 6, 13, 33 . In general, estimates of lies in the range (0< < 4), typically between 1 and 2 (between 95 pink and brown noise), often with "knee" frequencies described, where the 1/f spectrum appears 96 to deviate from linearity. Recently, Wen and Liu 34, 35 introduced a new method termed, Irregularly 97
Resampled AutoSpectral Analysis (IRASA) which utilises non-integer/reciprocal resampling of 98 a time-series to allow separate quantification of oscillatory and fractal components of the time-99 series and estimation of . In this work, we used IRASA to quantify the fractal component of the 100
ECoG/EEG/MEG power spectra, focussing on , its interaction with oscillatory rhythms and its 101 sensitivity to excitation-inhibition balance in the cerebral cortex. We demonstrate that the scalings 102 observed and the changes subsequently induced in them pharmacologically can be economically 103 accounted for if resting brain activity is viewed as arising from the collective behaviour of a 104 distribution of alpha-band relaxation processes. 105 106 Power (a.u.)
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MEG data were typically analysed in the source space ( Figure 1a and S1), which not only 118 permits more powerful inferences about source locations but helps to suppress both low and high-119 frequency artefacts 36 . IRASA was then used to estimate from the fractal part of the power 120 spectrum (Figure 1b) . Similar to others, we observed knee frequencies in the data and hence 121 divided the fits into a low frequency component denoted lf (0.1-2.5 Hz) and a high frequency 122 component hf (5-100 Hz unless otherwise specified). Figure 1c) shows comparable data and fits 123 can be obtained in MEG sensors and includes an example empty room noise recording. Our MEG 124 sensors generally showed a white noise profile ( >1Hz) in contrast to some MEG system sensors 125 which show more of a pink profile to nearly 100 Hz (see 37 Figure 30 ). (Figures 2a and 2b) , such that in the higher frequencies steeper slopes are present in posterior 144 areas whereas for the lower frequencies ( lf ) steeper slopes are present in the frontal cortex. Given 145 the spatial overlap of the higher frequencies with alpha generating areas, oscillatory alpha power 146 noted that hf values were generally highest and lf lowest in occipital areas, implying less overall 157 linearity in the scaling of the spectrum in these areas. A variety of pre-processing approaches 158 were used for the different recording modalities, suggesting that the observed correlations are 159 highly robust. We conducted multiple numerical simulations to confirm this effect was not an 160 artefact of the IRASA analysis procedure itself by producing artificial 1/f data with embedded 161 alpha oscillations at a range of signal-to-noise levels, hf values and variances (see Figures S7,  162 
S8). 163
Given the temporal correlation that exists within participants we examined whether across 164 participants a similar correlation exists. Inter-participant correlations were found such that those 165 participants who exhibit high alpha power have higher hf values ( Figures S9, S10 , S11, S12, 166 S13). Given the dynamical temporal relationships between hf and alpha power, we investigated, 167 but did not find, evidence of lag-lead effects using 1s data windows stepped forward in 100 ms 168 bins ( Figure S14 ). Correlations between lf and alpha power were explored, but we found little 169 evidence for such a relationship ( Figure S15 ). 170 The potential for hf and lf values to be modified by pharmacological intervention was 202 investigated in four pharmaco-MEG studies involving the GABA reuptake inhibitor tiagabine, the 203 non-selective NMDA receptor antagonist ketamine, the selective non-competitive AMPA 204 antagonist perampanel and the neuromodulator and serotonergic hallucinogen LSD. All drugs 205 were given at relatively low doses, which mostly caused sedation, apart from LSD which caused 206 cortex. In the oscillatory domain, a decrease in power, but acceleration of alpha oscillatory 224 frequency can be seen 39 . 225
Traditionally, quantitative EEG analysis, particularly in pharmaco-EEG is used to describe 226 the absolute and relative power in each of pre-defined frequency bands. However, quantification 227 of spectral power with IRASA allows subdivision into both fractal and oscillatory activity. For 228 each of the MEG studies, a typical quantitative MEG/EEG analysis was performed (see Figures 229 S16, S17 S18, S19). We note that the division of the spectrum into fractal and oscillatory modes 230 can reveal new insights into pharmacologically-induced spectral patterns, which are more 231 physiologically interpretable than relative EEG power. 232
Given the effects seen in pharmaco-MEG data, we investigated whether similar effects 233 exist in monkey ECoG data -here during anaesthesia induced by propofol and ketamine ( Figure  234 
5). Strong changes in
estimates were seen during these sessions, however, there was 235 significantly more regional variation than with the pharmaco-MEG data. The most consistent 236 effects were in the propofol hf parameter estimates which showed anterior increases and posterior 237 decreases. Clearly, averaging estimates across brain regions was not appropriate for these data. Initial attempts to correlate hf with alpha peak frequency and spectral width showed no 272 relationships. However, this may have been caused by noisy parameter estimation due to using 273 nonparametric (Fourier) spectral estimation. More accurate estimates of alpha full width at half 274 maximum (FWHM) and peak frequency were made using fixed-order autoregressive moving 275 average (ARMA) modelling (Figure 6 and S20). These showed that alpha-frequency FWHM is 276 strongly inversely correlated to alpha power and hence also to hf . The FWHM for alpha activity 277 from the ARMA analysis was typically around 2 Hz. Further, because the FWHM of a spectral 278 resonance in a white-noise driven damped linear oscillatory system is known to be proportional 279 to the temporal damping of the resonance, we also calculated the damping (− 6 , see middle panel 280 Figure 7 and Methods) of the alpha band oscillatory modes (poles) identified by our fixed-order 281 ARMA analysis. We found that alpha band power, total band power and hf were inversely 282 correlated with damping (Figure 6a-b) . We further investigated the relationships between hf , 283 alpha damping, and alpha power in each of the four pharmaco-MEG intervention experiments 284 (Figure 6c-f) . In general, it can be seen in both drug and placebo states hf is correlated with alpha 285 power, and alpha power is dependent on the degree of damping. A variety of drug-induced 286 parameter estimations can be seen. Tiagabine (Figure 6c Given the observed relationships between hf , alpha pole damping and power this suggests a 295 mechanistic explanation of electrophysiological spectra based on a collection of relaxation 296 processes. Because it is often empirically difficult to establish that spontaneous ECoG/EEG/MEG 297 results from an identifiable non-linear process it is often sufficient to describe its dynamical 298 behaviour in terms of a noise driven linear system having a number of characteristic oscillatory 299 modes. One of the simplest such possible characterisations involves assuming the existence oftwo damped oscillations -one having a frequency close to zero and another having a frequency 301 of alpha (f 9 ). In this case the resulting power spectrum is equal to the sum of two Lorentzians, 302 each of which is parameterised by the damping and frequency of the respective oscillatory modes. 303
This simple model can be further generalised to the case in which there are multiple alpha modes 304 having a distribution of dampings. We note from 40 that for a relaxation process having a frequency 305 f α and a distribution of dampings (p(σ)) the spectral density is given by: 306
To enable exact integration for the subsequent analytical calculation of a derivative with respect 310 to frequency (see Model fitting of electrophysiological spectra in Methods) we assume a 311 3 it can be seen that the EEG spectral shape can be controlled by four parameters, alpha peak 319 frequency f α, the damping probability distribution limits (σ l and σ h ) and m (when m=0 the 320 distribution reverts to a uniform distribution). In real data, ARMA analysis allows both σ l and < 321 to be explicitly measured where σ l is the most weakly damped pole (see Figure 7a ). m and σ h are 322 obtained by constrained fitting (see Model fitting of electrophysiological spectra in Methods). 323
Based on these equations we are able to account for the mechanistic generation of (1/f) 324 electrophysiological spectral data for both eyes open and closed data as well as during 325 pharmacological manipulation of the spectra by tiagabine, ketamine, LSD and perampanel (see 326 Methods, Figure 7b and Table S3 To test whether the generation of hf relies on underlying nonlinear mechanisms we subjected a 364 subset of the recorded data to nonlinearity testing using surrogate data generated using the iterated 365 amplitude fast Fourier transform method (IAFFT). These analyses (Figure 8 , Table S4 ) revealed 366 that approximately 39% (1060/2740) of the placebo hf estimates tested could be attributed to 367 non-linearity at = 0.05, with these estimates tending to fall at the more extreme values of hf . 368
Nonlinearity was not observed in hf estimates from synthetically produced data (pink noise with 369 embedded oscillations (see Figure S21 and S22 for an outline of the method used). Across drugs 370 we found that LSD significantly decreased the number of epochs that were nonlinear whereas 371 perampanel increased the number of epochs that were nonlinear, while ketamine and tiagabine 372 had no effect (see Table S4 ). 373 374 In these analyses we revealed for the first time striking dynamic correlations between oscillatory 388 alpha power and scale-free hf activity in ECoG/EEG/MEG in both humans and monkeys. 389
Contrary to prevailing views 42 we find that scale-free arrhythmic brain electromagnetic activity 390 can be robustly explained without the need to invoke mechanistically uncertain processes such as 391 self-organized criticality and fractal temporal dynamics. Analysis using theoretically motivated, 392 but empirically plausible, fixed-order ARMA models revealed that hf was significantly inversely 393 correlated with the damping of linear oscillatory modes in the alpha band during resting conditions 394 (Figure 4) . The existence of this inverse correlation suggests a clear explanation for the 395 relationship between alpha power and hf . In the simplest situation, consider a simple damped 396 harmonic oscillator in which the damping, and thus the FWHM and power, of the single 397 oscillatory mode can be modified. Reductions in the damping of this system will lead to higher 398 amplitude oscillations in the time domain and a narrowing of the spectral resonance in the 399 frequency domain. The narrowing of this spectral resonance will be associated with a steeper fall 400 off in power for higher frequencies. Therefore, the observed changes in alpha power can 401 potentially be understood as the result of alterations in the damping of a single oscillatory mode 402 having a resonant frequency within the alpha band. In our model, by a simple expansion of this to 403 a more physiologically realistic probability distribution of damped oscillatory poles, a rich array 404 of spectral behaviour can be explained. On this basis we are able to formally derive a relationship 405 (see Methods) between hf and the damping of alpha oscillatory activity and show that they are 406 negatively correlated (Figure 6 ). The model we propose is sufficient to explain normal resting 407 data as well as data from four interventional studies which showed various combinations of 408 oscillatory alpha power and hf changes. It may be that further expansion of this model is required 409 when other rhythms are included such as (coupled) beta/theta rhythms. This could be 410 accommodated by allowing more oscillatory modes and/or more complex damping probability 411 distributions. However, for the data under consideration the current model was sufficient to 412 explain all the data while allowing exact solutions. 413 we assumed that the relaxation processes arise solely from the decay of a perturbed linear system. 434
We have not investigated the possibility that non-linear relaxation processes, such as the decay of 435 a limit cycle oscillation within its basin of attraction, might also contribute to our empirical 436 estimates and their subsequent pharmacological modification, as such decay would also be 437 expected to contribute to the spectral broadening of the fundamental limit cycle oscillation 438
frequency. Clearly such a situation, which falls outside of the scope of this current 439 communication, needs to be studied. 440
Previously it has been shown that estimates of are increased in older adults 11 and 441 decreased in patients with schizophrenia 45 . Hitherto, such differences between population groups 442 could potentially be explained away by potential physiological differences in tissue filtering 443
properties of the extracellular media, which can modify estimates 23, 24 . However, tissue filtering 444 alone cannot explain our results where we see modifications that occur within participants, both 445 dynamically and following pharmacological interventions. As such, our work suggests an 446 alternate interpretation for the modification of estimates seen in special population groups. That 447 is, differences may reflect modifications of cortical excitation-inhibition balance on alpha pole 448 damping. For ageing, most likely this could be attributed to decline in the GABA system with age. 449
Several studies have noted reduced GABA concentration in humans 46 , and monkey 47 measured 450 with MRS, as well as reduced oscillatory gamma-frequency in humans 46 , which is thought to 451 depend on GABAergic mechanisms. Functionally-related decreased proportions of GABA 452 interneurons have been observed in cat visual cortex 48 and indeed GABA agonists can restore 453 visual function in ageing monkeys 49 . 454
In these results we found generalised decreases in hf and increases of lf with ketamine 455 in humans, whereas while the ECoG data in monkeys showed strong effects on these parameters, 456 these were more variable in terms of spatial location, direction and across animal. Notably, thehuman data was collected at subanaesthetic doses (0.3 mg/kg) whereas the anaesthesia data is 458 obtained at doses ~5 mg/kg. While ketamine is primarily considered an NMDA antagonist, it has 459 a mixed pharmacology at clinically relevant concentrations, including but not limited to, actively 460 inhibiting hyperpolarisation-activated cyclic nucleotide (HCN) channels, facilitating delta and mu 461 opioid activity as well increasing release of dopamine and noradrenaline (see 50 ). These mixed 462 activities become increasingly relevant at increasing concentrations, for example, the EC 50 of 463 ketamine for NMDA channels is 1-5 µM and slightly higher for HCN channels (8-16 μM) 51 . HCN 464 channels, which mediate a depolarising inward current in response to hyperpolarisation, might be 465 particularly relevant, given that HCN knockout mice show twofold less sensitivity to the hypnotic 466 actions of ketamine 51 . Similarly, propofol also causes inhibition 51 of HCN with decreased 467 propofol sensitivity observed in HCN knockout mice. Moreover, neural field modelling of the 468 EEG suggests that much of the effects of ketamine and propofol on EEG rhythmicity can be 469 accounted for by their activity at HCN channels rather than primary NMDA/GABAergic effects 470
Methods 499 500

Description of data sources 501 502
Data were re-analysed from four pharmaco-MEG studies involving the drugs tiagabine, ketamine, 503 perampanel and LSD [29] [30] [31] 53 . The reader is referred to those papers for comprehensive descriptions 504 of the experiments but key features are briefly recapitulated here and in Table S1 . All whole-head 505 MEG recordings were made using a CTF 275-channel radial gradiometer system sampled at 1200 506 Hz (0-300 Hz bandpass). An additional 29 reference channels were recorded for noise 507 cancellation purposes and the primary sensors were analysed as synthetic third-order gradiometers 508 54 . 509
Unpublished EEG data from 5 minute eyes-closed recordings were also analysed. The 510 participants consisted of seventeen healthy male participants (mean age = 23). Participants were 511 seated with their eyes-closed. 64 channel EEG was recorded continuously (1000 Hz sampling 512 rate; 0.1 µV resolution, 250 Hz low pass filter) using Acticap Ag/AgCl active shielded electrodes 513 with Brain Products MR Plus amplifiers (Brain Products GmbH, Munich, Germany). All electrode 514 impedances were typically maintained below 10 kΩ. EEG was acquired using an FCz reference 515 and a ground electrode located at AFz. 516
Monkey electrocorticographic data were downloaded from the publicly available 517 neurotycho database (http://neurotycho.org/) 55 . From this data we selected recordings from two 518 monkeys, "George" and "Chibi". Both these monkey had data from two sessions of propofol 519 anaesthesia (~5 mg/kg intravenous propofol) and another two sessions with ketamine anaesthesia 520 Pre-processing of data was performed using custom scripts based on the Fieldtrip toolbox 16 . 526
Continuous MEG data were first visually inspected and those sections of data with gross artefacts 527 were removed from the data. Datasets were excluded if data were not of acceptable quality (e.g. 528 excessive artefact sections). Independent component analysis (ICA), as implemented in Fieldtrip/ 529 EEGLAB was then performed on the remaining data sections. Visual inspection was used to 530 identify components related to ocular, cardiac and muscular artefacts and these components were 531 then projected out of the data. Source modelling of the data was performed using the Fieldtriptoolbox 16 . For each participant individual forward models were generated from their individual 533 structural MRI scan using a "single-shell" model 56 . Due to computational complexity of 534 subsequent processing with IRASA, in order to reduce the data, an atlas-based beamformer 535 approach was used 57 . Broadband virtual sensor time-series were constructed using a linearly 536 constrained minimum variance beamformer with 5% regularisation 58 at 90 cortical and 537 subcortical seed locations as specified in the automated anatomical labelling atlas 38 . Frequency 538 spectra were calculated and inspected for each dataset to "sanity-check" the source solutions. 539 540 EEG pre-processing 541
542
Similar to the MEG data, continuous EEG data were first visually inspected and those sections of 543 data with gross artefacts were removed. Datasets were excluded if data were not of acceptable 544 quality (e.g. excessive artefact sections). Bad channels were also removed at this stage and then 545 ICA used to remove artefacts. As individual MRI scans were not available no source modelling 546 on these data were performed. After artefact removal, data were average-referenced and any 547 missing channels were replaced using spherical-spline interpolation 59 . 548
549
ECoG pre-processing 550
551
Three sections of each recording day were considered for analysis, resting eyes-open, eyes-closed 552 and anaesthesia. These sections were extracted from the data using annotated event-markers. Each 553 dataset contained 128 electrodes and using the provided electrode maps, 64-channel bipolar 554 montages were computed to reduce any far-field artefact contamination 60 Fourier Transform (FFT). Prior to FFT computation, data is tapered with a Hanning window and 570 a length of FFT is used such that it is the next power of two after multiplying the sub-epoch data 571 length by the largest resampling value to be used (h(max) -see later). The average spectral power 572 of the sub-epochs is taken as an estimate of the total (mixed) power spectrum. The sub-epochs are 573 then resampled using a range of resampling factors (h) and their reciprocals (1/h). We set h=1.1 574 to 2.9 in steps of 0.05 with h≠2. The sub-epochs are upsampled for one of the reciprocal pairs, 575 using cubic spline interpolation and are downsampled with a similar interpolation scheme, but 576 following low-pass filtering to avoid aliasing for the other reciprocal pair. The mean of each 577 upsampled sub-epoch for a given h,1/h pair is calculated, and then the median across h values is 578 calculated as a representation of the fractal power for the epoch. The oscillatory power spectrum 579 is then calculated as the difference between the total and fractal power spectrum. The IRASA 580 process is depicted in Figure S1 . It should be noted that the primary free parameter is the choice 581 of resampling factors h. A larger range of h provides better suppression of residual oscillatory 582 power in the fractal power spectrum, at the expense of a reduction in the highest frequency 583 available for analysis. Given that all the datasets we analysed were sampled at 1000Hz or greater, 584
with an h(max)=2.9, this left a maximum resolvable frequency of 250 Hz. Unless otherwise 585 specified, data were divided into sections of 10s length ready prior to computation of IRASA. The 586 length of the data epoch sets the lowest frequency available for analysis. For epochs of 10s 587 duration sampled at 1,000Hz this is 0.03 Hz. We note that while Liu and Wen 34, 35 set h =1.1 to 588 1.9 in steps of 0.05 we found in some of our data cases, those settings led to residual spectral 589 mixing (identifiable as a bump in the log-log spectra). Hence a broader range for h was used here. 590
In order to estimate the power law exponent (b), the fractal power spectrum was transformed to 591 log-log coordinates and linear regression performed. To avoid biasing regression estimates 592 towards the higher frequencies, where more sampling points exist in logarithmic space, frequency 593 estimates are resampled to be evenly spaced in logarithmic coordinates prior to computation of 594 the regression. where solutions to A(z)= 0 will give the system poles and solutions to B(z)=0 give the system 627 zeros. The poles correspond to the dominant oscillations in the signal or the peaks in the power 628 spectrum of the signal, while the zeros essentially indicate frequencies where power is nulled. 629
Together this allowed several parameters to be extracted for alpha (8-13Hz) including, peakfrequency, power at peak frequency (peak power), the integrated power in the 8-13Hz band (band 631 power) and full-width at half-maximum (FWHM). A parameter estimating alpha-band "damping" 632 (− 6 ) was estimated directly from the AR parameters. The damping parameter quantifies how 633 quickly the oscillation will decay over time after it has been perturbed and the boundary parameter 634 where no power is present. Specifically 6 was calculated as − P ln , where P is the sampling 635 frequency and the average modulus of all poles having a frequency between 8 and 13Hz. To estimate m and F we define the log-log frequency scaling of < , FR , as the slope of 643 log ]a < 10 j evaluated at the logarithm of the midpoint frequency over which FR was 644 empirically estimated, i.e. where the dependence on 6 , F , is made explicit. On the basis that the most weakly damped 649 alpha modes, 6 , can be estimated directly from the ARMA analysis and under the simplest 650 assumption that the distribution of dampings are uniform (i.e. = 0) solutions to 651 FR 6 , F , = 0 = FR will enable us to uniquely estimate F (see Table S3 ). In the case that 652 no solution can be found for = 0 a non-uniform distribution of dampings was assumed. 653
However, this results in an under-determined problem and thus additional constraints were applied 654 in order to find a solution. The constraint we choose to apply is one that minimises the 655 Kolmogorov-Smirnov distance between a prior uniform placebo distribution, as estimates of 656 F can be found for all placebo conditions for = 0, and a resulting posterior distribution for a 657 drug condition that arises as a solution to FR 6 , F , ≠ 0 = FR . 658 659 660 661
